1[1]Patricia AG, Kandice KM, Emilio DP, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J]. Am J Cardiol , 2001, 88:230.
2[2]Eikelboom JW, Hirsh J, Weit JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke, or cardiovascular death in patients at high risk for cardiovascular events[J]. Circulation, 2002, 105 :1 650.
3[3]Patrono C, Coller B, Dalen JE. et al. Platelet-active drugs:The relationships among dose, effectiveness, and side effeets[J]. Chest, 1998,114:470s.
4[4]Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthesis in symptomatic atherosclerotic plague as abasis of prostaglandin E (2)-dependent plaque instability [ J ]. Circulation,2001, 104:921.
5[5]Pratico D, Cheng Y, Fitz Gerald GA. TP or Not TP: Primary mediators in a close runoff[J]. Arterioscler Thromb Vasc Biol,2000, 20:1 695.
同被引文献3
1Born G V R. Aggregation of blood platehs by adenosine diphosphate and its reversal[ J ]. Nature, 1962,194 : 927-929.
